OROPHARYNX CANCER, RECURRENT
Clinical trials for OROPHARYNX CANCER, RECURRENT explained in plain language.
Never miss a new study
Get alerted when new OROPHARYNX CANCER, RECURRENT trials appear
Sign up with your email to follow new studies for OROPHARYNX CANCER, RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy may replace chemo in head and neck cancer trial
Disease control OngoingThis study tests whether the immunotherapy drug pembrolizumab (Keytruda) combined with radiation works better than the standard chemotherapy drug cisplatin with radiation for patients with a certain type of head and neck cancer (p16-positive). About 126 adults with advanced or in…
Matched conditions: OROPHARYNX CANCER, RECURRENT
Phase: PHASE2 • Sponsor: Loren Mell, MD • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Simple blood test may spot returning throat cancer sooner
Knowledge-focused OngoingThis study looks at whether a blood test that finds HPV DNA can spot throat cancer coming back after treatment, possibly earlier than usual scans. Researchers will follow 200 patients with HPV-positive oropharyngeal cancer to see how accurate the test is. The goal is to improve m…
Matched conditions: OROPHARYNX CANCER, RECURRENT
Sponsor: Rigshospitalet, Denmark • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC